Psychosocial Supports

Includes depression-related items from the Primary Care Evaluation of Mental Disorders (PRIME-MD) diagnostic tool for common mental disorders in a 9-item scale. Helps clinicians make a tentative diagnosis of depression and to monitor depression severity and response to treatment in the past 2 weeks.

Assesses quality of life across physical, psychological, social, and environmental domains.

Offers a 5-item scale designed to measure global cognitive judgments of one's life satisfaction (not a measure of either positive or negative affect). Prompts participants to indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 7 (strongly agree) to 1 (strongly disagree).

Aims to promote awareness for the evidence base and promise of motivational interventions and shows how clinicians can influence motivation by developing a therapeutic relationship with the client. Describes different motivational interventions that can be used at all stages of change.

Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.

Assesses symptoms of anxiety using a 7-item questionnaire that asks whether the patient has experienced anxiety-related problems in the previous 2 weeks and the impact they have had on the individual's life.

Assesses a person's belief of "being in control" in situations involving drug abuse. Consists of 16-item pairs presented in a forced-choice format.

Assesses perception of one's capacity to refrain from attempting suicide with a 6-item assessment that rates items on a 10-point scale ranging from 0 (very uncertain) to 9 (very certain).

Discusses psychosocial treatment buprenorphine patients should receive.

Provides information on available mental health or substance use treatment services by allowing users to search by Zip Code